Zobrazeno 1 - 10
of 1 230
pro vyhledávání: '"C, Trépo"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
U Vickos, S Ghosh, M Abdou-Chekaraou, N Al Hawajri, A Manirakiza, C Bekondi, S Brichler, J O Ouavènè, A Sépou, G Laghoe, J Gody, V Fikouma, N Samarakoon, D Alfaiate, C Scholtès, N Martel, F Le Gal, H Lo Pinto, I Amri, O Hantz, D Durantel, J L Lesbordes, E Gordien, P Merle, C Trépo, F Zoulim, C Cortay, A Kay, P Dény, N Komas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::33dc9710f1533e28f5ca7ce36001092a
Autor:
C. Trépo, Fabien Zoulim
Publikováno v:
Gastroentérologie Clinique et Biologique. 33:811-817
Despite the development of new anitiviral agents, the treatment of chronic hepatitis B remains a major clinical challenge. Major achievements have been made with the rationale use of antivirals exhibiting a complementary cross resistance profile to p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f56d9ba75e2f2bc63cb228bf6ae030a3
https://doi.org/10.1016/j.gcb.2009.04.005
https://doi.org/10.1016/j.gcb.2009.04.005
Publikováno v:
Transfusion Clinique et Biologique. 10:292-306
GB virus-C alias "hepatitis" virus G was discovered in 1995 as a putative causative virus of non A-E hepatitis. It is a very common virus found in 1 to 5% of eligible blood donors in developed countries. Numerous studies over seven years led to the e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0af61092202d32249a6b2809b1992648
https://doi.org/10.1016/s1246-7820(03)00095-8
https://doi.org/10.1016/s1246-7820(03)00095-8
Autor:
S, Nafa, S, Ahmed, D, Tavan, C, Pichoud, F, Berby, L, Stuyver, M, Johnson, P, Merle, H, Abidi, C, Trépo, F, Zoulim
Publikováno v:
Hepatology. 32:1078-1088
We have analyzed the molecular dynamics of emergence of drug-resistant strains in patients receiving lamivudine therapy for chronic hepatitis B. Twenty consecutive patients with lamivudine resistance were studied (13 hepatitis B e antigen [HBeAg]-pos
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c5abb9006c21a28c901181179415888a
https://doi.org/10.1053/jhep.2000.19619
https://doi.org/10.1053/jhep.2000.19619
Autor:
C. Trépo, P. Miailhes
Publikováno v:
Médecine et Maladies Infectieuses. 30:S8-S13
Resume L'infection a virus de l'hepatite C (VHC) est une maladie frequente qui touche 150 millions de sujets dans le monde. Son histoire naturelle est composee d'une phase primaire puis d'une phase d'infection chronique, generalement associee a une m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::de6cc4a925c2311d959ed0b999b4615a
https://doi.org/10.1016/s0399-077x(00)88855-1
https://doi.org/10.1016/s0399-077x(00)88855-1
Publikováno v:
Gastroenterologie clinique et biologique. 33(8-9)
Despite the development of new anitiviral agents, the treatment of chronic hepatitis B remains a major clinical challenge. Major achievements have been made with the rationale use of antivirals exhibiting a complementary cross resistance profile to p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::861b4c2db047d970b295782dd1849f2f
https://pubmed.ncbi.nlm.nih.gov/19560888
https://pubmed.ncbi.nlm.nih.gov/19560888
Publikováno v:
Gastroenterologie clinique et biologique. 32(3 Pt 2)
After a treatment by peginterferon alpha and ribavirin, the percentages of non response and relapse are approximatively 33 and 18 % respectively. These treatment failures may be due either to viral resistance or to an insufficient treatment. The prev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b55bedebcc4aa0a59c483eeeed1061a8
https://pubmed.ncbi.nlm.nih.gov/18675180
https://pubmed.ncbi.nlm.nih.gov/18675180
Autor:
P, Martin, P, Parroche, L, Chatel, C, Barretto, A, Beck, C, Trépo, C, Bain, Y C, Lone, G, Inchauspé, Anne, Fournillier
Publikováno v:
Journal of medical virology. 74(3)
Interferon-gamma (IFN gamma)-producing CD8+ T cells have been shown to play a key role in the control or eradication of hepatitis C virus (HCV) infections. In particular, T cells specific of the non-structural protein 3 (NS3) are often associated wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9ee6c80915d0a05d013db62bb71bfa59
https://pubmed.ncbi.nlm.nih.gov/15368525
https://pubmed.ncbi.nlm.nih.gov/15368525